Tabituximab barzuxetan (exclude Y90), CAS 1612758-88-9

Product Description: Tabituximab barzuxetan (exclude Y90) is a radioimmunoconjugate composed of a humanized monoclonal antibody targeting FZD-10 (OTSA-101). Tabituximab barzuxetan shows antineoplastic activity. Tabituximab barzuxetan can be used for synovial sarcoma research[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Anne-Laure Giraudet , et al. A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients. BMC Cancer. 2018 Jun 8;18(1):646.

CAS Number: 1612758-88-9

Molecular Weight: N/A

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Wnt

• Artikelnummer: MEXHY-P99581-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99581-1
• Green Labware: Nein
• Verpackungseinheit: 1mg
• Mengeneinheit: STK